Use this data to counsel patients on maintenance, exercise programming, and whether dose adjustment is warranted
Multivariable analysis identified Semaglutide dosage, baseline ASMI, and gait speed as independent predictors of muscle loss
For clinicians and patients, it should not be assumed that lack of substantial weight loss on semaglutide would preclude the opportunity for improved cardiovascular outcomes
Palmitate, partly a product of hepatic de novo lipogenesis, has a particularly detrimental role in reducing -cell function, most likely by inducing -cell dedifferentiation 50
Beyond GI AEs, semaglutide was found to associate with a higher incidence of gallbladder-related disorders, primarily cholelithiasis [13, 40, 42, 44,45,46], and acute pancreatitis [13, 39, 42, 44] compared with placebo
My doctor also expressed concern about my weight and high cholesterol